Towards a genetic AIDS vaccine

<p>Abstract</p> <p>We discuss a recent Nature Medicine publication by Philip Johnson and co-workers (Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. <it>Nat. Med</it>. 2009, 15: 901-906) in which...

Full description

Bibliographic Details
Main Authors: Berkhout Ben, Bordería Antonia V
Format: Article
Language:English
Published: BMC 2009-10-01
Series:Retrovirology
Online Access:http://www.retrovirology.com/content/6/1/93
id doaj-8a7fbb5fb21849aba4719cb1039572ea
record_format Article
spelling doaj-8a7fbb5fb21849aba4719cb1039572ea2020-11-24T21:40:17ZengBMCRetrovirology1742-46902009-10-01619310.1186/1742-4690-6-93Towards a genetic AIDS vaccineBerkhout BenBordería Antonia V<p>Abstract</p> <p>We discuss a recent Nature Medicine publication by Philip Johnson and co-workers (Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. <it>Nat. Med</it>. 2009, 15: 901-906) in which an effective HIV-1 vaccine was designed that is based on gene therapy. The introduced gene produces an antibody-like immunoadhesin in the blood that neutralizes the virus.</p> http://www.retrovirology.com/content/6/1/93
collection DOAJ
language English
format Article
sources DOAJ
author Berkhout Ben
Bordería Antonia V
spellingShingle Berkhout Ben
Bordería Antonia V
Towards a genetic AIDS vaccine
Retrovirology
author_facet Berkhout Ben
Bordería Antonia V
author_sort Berkhout Ben
title Towards a genetic AIDS vaccine
title_short Towards a genetic AIDS vaccine
title_full Towards a genetic AIDS vaccine
title_fullStr Towards a genetic AIDS vaccine
title_full_unstemmed Towards a genetic AIDS vaccine
title_sort towards a genetic aids vaccine
publisher BMC
series Retrovirology
issn 1742-4690
publishDate 2009-10-01
description <p>Abstract</p> <p>We discuss a recent Nature Medicine publication by Philip Johnson and co-workers (Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. <it>Nat. Med</it>. 2009, 15: 901-906) in which an effective HIV-1 vaccine was designed that is based on gene therapy. The introduced gene produces an antibody-like immunoadhesin in the blood that neutralizes the virus.</p>
url http://www.retrovirology.com/content/6/1/93
work_keys_str_mv AT berkhoutben towardsageneticaidsvaccine
AT borderiaantoniav towardsageneticaidsvaccine
_version_ 1725926853223383040